BIOPHYTIS (EPA:ALBPS) - Biophytis announces promising full results from the SARA-INT Phase 2b trial of Sarconeos (BIO101) in Sarcopenia at the 11th annual International Conference on Frailty and Sarcopenia Research (ICFSR) September 29 – October 2, 2021
Transparency directive : regulatory news
04/10/2021 08:00